Avidity Partners Management’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,150,000
| Closed | -$3.74M | – | 88 |
|
|
2024
Q1 | $3.74M | Buy |
1,150,000
+10,000
| +0.9% | +$32.5K | 0.12% | 78 |
|
|
2023
Q4 | $23.4M | Buy |
1,140,000
+50,600
| +5% | +$1.04M | 0.85% | 44 |
|
|
2023
Q3 | $17.5M | Buy |
1,089,400
+432,200
| +66% | +$6.95M | 0.71% | 54 |
|
|
2023
Q2 | $5.59M | Sell |
657,200
-66,000
| -9% | -$561K | 0.2% | 79 |
|
|
2023
Q1 | $7.14M | Sell |
723,200
-20,400
| -3% | -$201K | 0.24% | 69 |
|
|
2022
Q4 | $7.09M | Buy |
743,600
+970
| +0.1% | +$9.24K | 0.15% | 63 |
|
|
2022
Q3 | $12.9M | Buy |
742,630
+54,300
| +8% | +$944K | 0.26% | 63 |
|
|
2022
Q2 | $5.34M | Hold |
688,330
| – | – | 0.12% | 57 |
|
|
2022
Q1 | $10.4M | Buy |
+688,330
| New | +$10.4M | 0.22% | 62 |
|